Catalyst Wire Dossier Catalyst Wire Dossier

SA-ER (Sialic Acid-Extended Release) tablets

sialic acid extended-release · Ultragenyx Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SA-ER (Sialic Acid-Extended Release) tablets, covering 2016-06-16 to 2016-06-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy [Phase 2]

See pricing